{"ticker": {"uuid": "7fe5ac59-c409-4f2e-a873-413f8ced0566", "symbol": "177A", "name": "KOHJIN BIO CO LTD", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Entering the Contract Manufacturing Business for Cell Culture Media for Regenerative Medicine Ajinomoto Co., Inc. and Kohjin Bio Co., Ltd., a Leading CDMO for Cell Culture Media for Regenerative Medicine, Agree to Establish a Joint Venture Company Esta", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPUGRlNFhSNWM2T3AtRXI4QWh5Sjhfc0JNZC12bGtSWGlDb2N4UTdoU3gzb0I5MVBmajJsUUxQa2dJeGRwTEpRYzdpblNvajRzQmNjWEJqZTR4eXdpYUhUMDF3Z1BEb2hvZjJEUEJ5S2xkdS1WTjdmb3ByZWJ1akpXWjRHaTA4Y28?oc=5", "source_name": "\u5473\u306e\u7d20\u682a\u5f0f\u4f1a\u793e", "published_at": "2018-05-22T07:00:00+00:00", "published_display": "22 May 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Entering the Contract Manufacturing Business for Cell Culture Media for Regenerative Medicine Ajinomoto Co., Inc. and Kohjin Bio Co., Ltd., a Leading CDMO for Cell Culture Media for Regenerative Medicine, Agree to Establish a Joint Venture Company Esta", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPUGRlNFhSNWM2T3AtRXI4QWh5Sjhfc0JNZC12bGtSWGlDb2N4UTdoU3gzb0I5MVBmajJsUUxQa2dJeGRwTEpRYzdpblNvajRzQmNjWEJqZTR4eXdpYUhUMDF3Z1BEb2hvZjJEUEJ5S2xkdS1WTjdmb3ByZWJ1akpXWjRHaTA4Y28?oc=5", "source_name": "\u5473\u306e\u7d20\u682a\u5f0f\u4f1a\u793e", "published_at": "2018-05-22T07:00:00+00:00", "published_display": "22 May 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 67, "total_relevant": 1, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 1, "score": 50, "total": 1, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 72, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 858.0, "latest_week": "2026-07-10", "one_week_move": -1.2, "four_week_move": -12.8, "twelve_week_move": -37.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.892679, "market_dynamics_buy_signal": false, "relative_strength": -53.921476, "fair_value_gap": -45.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 52.929, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.2% over one week, -12.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "\u5473\u306e\u7d20\u682a\u5f0f\u4f1a\u793e", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 1}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "1", "tone": "neutral", "text": "directly relevant article"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.2% over one week, -12.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Entering the Contract Manufacturing Business for Cell Culture Media for Regenerative Medicine Ajinomoto Co., Inc. and Kohjin Bio Co., Ltd., a Leading CDMO for Cell Culture Media for Regenerative Medicine, Agree to Establish a Joint Venture Company Esta"}], "updated_at": "2026-07-17T21:06:04.307724+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}